About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:3622103
Allelic
Composition
Fkbp1atm1Zuk/Fkbp1atm1Zuk
Genetic
Background
either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6J)
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fkbp1atm1Zuk mutation (0 available); any Fkbp1a mutation (14 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• only a few (8) homozygotes survive to weaning; however, 7 of 8 die within a few weeks because of a cardiac-related wasting syndrome while the eighth one survived to 14 months
• most homozygotes die between E14.5 and birth
• at E18.5, most homozygotes exhibit rapid demise suggesting perfusion failure

cardiovascular system
• at E14.5 and E18.5, most homozygotes exhibit noncompaction of left ventricular myocardium
• at E14.5 and E18.5, homozygotes display hypertrophic trabeculae with deep intertrabecular recesses
• at E14.5 and E18.5, homozygotes exhibit prominent ventral septal defects
• at E18.5, most homozygotes display a significantly increased heart weight relative to wild-type mice (13.4 0.44 mg vs 8.14 0.38 mg)
• at E14.5 and E18.5, homozygotes display a thinner left ventricular wall
• at E18.5, most homozygotes display an enlarged heart due to four-chamber dilation
• homozygotes exhibit severe dilated cardiomyopathy associated with aberrant single-channel gating properties of both skeletal and cardiac ryanodinereceptors
• at E14.5, many homozygotes exhibit severe liver hemorrhage
• a single 14-mo-old homozygote displayed reduced contractile activity in the ventricular wall, as shown by reduced fractional shortening (%FS = 19.9%) and ejection fraction (%EF = 35.8%) relative to wild-type (%FS = 41.6%; %EF = 65.1%)

growth/size/body
• at E18.5, most homozygotes display a significantly increased heart weight relative to wild-type mice (13.4 0.44 mg vs 8.14 0.38 mg)

homeostasis/metabolism
• at E14.5, about 50% of homozygotes are edematous consistent with an early heart defect

respiratory system
• at E18.5, most homozygotes gasp for breath

nervous system
• at E9.5, homozygous mutant embryos exhibit an open cranial neural tube
• 9% of E14.5 and 4% of E18.5 homozygotes display exencephaly with a 'cauliflower-like' protrusion of the mutant brain

muscle
• at E14.5 and E18.5, most homozygotes exhibit noncompaction of left ventricular myocardium
• at E14.5 and E18.5, homozygotes display hypertrophic trabeculae with deep intertrabecular recesses
• homozygotes display an apparently normal skeletal muscle development through embryogenesis; however, lipid bilayer experiments indicate that both skeletal (RyR1) and cardiac (RyR2) ryanodinereceptors show altered single-channel properties
• homozygotes exhibit severe dilated cardiomyopathy associated with aberrant single-channel gating properties of both skeletal and cardiac ryanodinereceptors
• a single 14-mo-old homozygote displayed reduced contractile activity in the ventricular wall, as shown by reduced fractional shortening (%FS = 19.9%) and ejection fraction (%EF = 35.8%) relative to wild-type (%FS = 41.6%; %EF = 65.1%)

liver/biliary system
• at E14.5, many homozygotes exhibit severe liver hemorrhage
• at E14.5, many homozygotes exhibit prominent liver necrosis

embryo
• at E9.5, homozygous mutant embryos exhibit an open cranial neural tube

integument
• at E18.5, most homozygotes show pallor despite normal hematocrits

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
Barth syndrome DOID:0050476 OMIM:302060
J:45536


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory